Michelle Meng Huang Mok

4PUBLICATIONS
39CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)MechanobiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 20, 2025
An Upstream RUNX3 Enhancer, eR3 (-18m/-28h), Regulates the Development of Gut-Associated Anti-Tumorigenic CD8+CD103+ Cytotoxic T Lymphocytes in Mouse and Human.

Giselle Sek Suan Nah, Junichi Matsuo, Avinash Govind Bahirvani

|Nov 20, 2024
ZBTB48 is a priming factor regulating B-cell-specific CIITA expression.

Grishma Rane, Vivian L S Kuan, Suman Wang

|Jun 20, 2021
RUNX1-ETO (RUNX1-RUNX1T1) induces myeloid leukemia in mice in an age-dependent manner.

Mohamed Gaber Abdallah, Akiko Niibori-Nambu, Mariko Morii

|Dec 15, 2019
Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapy.

Ekta Khattar, Kyaw Ze Ya Maung, Chen Li Chew

Pageof 1

Frequent Collaborators

2 joint publications

Motomi Osato

1 joint publications

Arkasubhra Ghosh

1 joint publications

Gökhan Cildir

1 joint publications

Alan Prem Kumar